FreshPatents.com Logo
stats FreshPatents Stats
4 views for this patent on FreshPatents.com
2010: 1 views
2009: 3 views
newTOP 200 Companies
filing patents this week



Advertise Here
Promote your product, service and ideas.

    Free Services  

  • MONITOR KEYWORDS
  • Enter keywords & we'll notify you when a new patent matches your request (weekly update).

  • ORGANIZER
  • Save & organize patents so you can view them later.

  • RSS rss
  • Create custom RSS feeds. Track keywords without receiving email.

  • ARCHIVE
  • View the last few months of your Keyword emails.

  • COMPANY DIRECTORY
  • Patents sorted by company.

Follow us on Twitter
twitter icon@FreshPatents

Browse patents:
Next →
← Previous

Novel antimicrobial bolisin peptides


Title: Novel antimicrobial bolisin peptides.
Abstract: The invention relates to antibiotically effective peptides which are prepared for medical and commercial use by using biotechnological methods and chemical synthesis. The antibiotically effective peptides can be used in a suitable galenic formulation as medicaments/animal medicaments, food additives or as preservatives for the prevention of microbial contaminations of cosmetics, medical products and requisites. ...

Browse recent Ipf Pharmaceuticals Gmbh. patents
USPTO Applicaton #: #20090149391 - Class: $ApplicationNatlClass (USPTO) -
Inventors: Cornelia Liepke, Susann Baxmann, Knut Adermann



view organizer monitor keywords


The Patent Description & Claims data below is from USPTO Patent Application 20090149391, Novel antimicrobial bolisin peptides.

The invention relates to peptides having a highly effective antimicrobial activity, processes for the preparation thereof, and the use thereof.

It is known that naturally occurring peptides may be antibiotically effective. Thus, WO 97/35877 describes the occurrence and purification of antibiotic peptides from cow's milk, and PCT/EP 01/06518 describes the recovery of antimicrobial peptides from human placenta extract and from bovine thymus extract, and their application.

One of the peptides purified from bovine thymus extract is bolisin (PCT/EP 01/06518, SEQ ID No. 5). Bolisin is a fragment of the bovine mitochondrial proteolipid comprising 17 amino acids, and it inhibits the growth of pathogenic microorganisms in low-salt nutrient media.

It is an object of the invention to provide bolisin-based peptides which have a particularly high specific activity under different conditions. It is also an object of the invention to provide peptides which inhibit the growth of microorganisms in environments with physiological salt concentrations and at the same time have as low as possible a hemolytic activity.

Surprisingly, this object is achieved by providing peptides of the sequence


R1-ZX3X3X1BX3RX2X3X4BRX2BX3X3B—R2,

wherein

R1 represents an amino group (NH2), an amino acid or a peptide having up to 10 amino acids, and R2 represents COOH, CONH2, an amino acid or a peptide having up to 10 amino acids;

Z represents an aromatic amino acid (W, Y, F), preferably tyrosine (Y) or an amino acid mono- or polyhalogenated at the aromatic moiety, preferably tyrosine (Y);

X1 represents arginine (R) or an aromatic amino acid (W, Y, F), preferably tryptophan (W) or an amino acid mono- or polyhalogenated at the aromatic moiety, preferably tryptophan;

X2 represents serine (S), a basic amino acid (R, K), preferably arginine (R), or an aromatic amino acid (W, Y, F), preferably tryptophan (W) or an amino acid mono- or polyhalogenated at the aromatic moiety, preferably tryptophan;

X3 represents threonine (T), a hydrophobic amino acid (I, V, A, L) or arginine (R);

X4 represents aspartic acid (D), proline (P), a basic amino acid (K, R), preferably arginine (R), or an aromatic amino acid (W, Y, F), preferably tryptophan (W) or an amino acid mono- or polyhalogenated at the aromatic moiety, preferably tryptophan; and

B represents a basic amino acid (K, R).

The invention also relates to derivatives and/or fragments of the peptides according to the invention having antimicrobial activity, especially the derivatives and/or fragments which are amidated, acylated, acetylated, alkylated, sulfated, phosphorylated, halogenated, especially halogenated at aromatic amino acid side chains, glycosylated, oxidized, modified by esterification or lactone formation, and/or cyclized. Halogenated peptides are preferably halogenated at aromatic residues of amino acid side chains. The amino acids are designated with the one-letter code.

Preferably, the peptides according to the invention have the following sequences:

R1-ZIX3X1BX3RX2ADBRX2BALB-R2 (Sequence ID Nos.: 2, 4, 8, 12, 13, 15) R1-ZIX3X1BX3RX2APBRX2BALB-R2 (Sequence ID No.: 11) R1-ZIX3X1BX3RX2ABBRX2BALB-R2 (Sequence ID Nos.: 1, 3, 5, 6, 7, 9, 10, 18, 21-24, 28, 29, 31, 32, 35, 38, 41, 45, 47, 48, 51) R1-ZIX3X1BX3RX2AZBRX2BALB-R2 (Sequence ID Nos.: 14, 16, 17, 19, 20, 25-27, 30, 33, 34, 36, 37, 42-44, 46, 49, 50, 52, 53, 54) R1-ZIX3X1BX3RX2TZBRX2BALB-R2 (Sequence ID No.: 55)


← Previous       Next → Advertise on FreshPatents.com - Rates & Info


You can also Monitor Keywords and Search for tracking patents relating to this Novel antimicrobial bolisin peptides patent application.
###
monitor keywords

Browse recent Ipf Pharmaceuticals Gmbh. patents

Keyword Monitor How KEYWORD MONITOR works... a FREE service from FreshPatents
1. Sign up (takes 30 seconds). 2. Fill in the keywords to be monitored.
3. Each week you receive an email with patent applications related to your keywords.  
Start now! - Receive info on patent apps like Novel antimicrobial bolisin peptides or other areas of interest.
###


Previous Patent Application:
Kinase inhibitors and uses thereof
Next Patent Application:
Oxidant resistant apolipoprotein a-1 and mimetic peptides
Industry Class:
Drug, bio-affecting and body treating compositions
Thank you for viewing the Novel antimicrobial bolisin peptides patent info.
- - -

Results in 0.02305 seconds


Other interesting Freshpatents.com categories:
Medical: Surgery Surgery(2) Surgery(3) Drug Drug(2) Prosthesis Dentistry  

###

Data source: patent applications published in the public domain by the United States Patent and Trademark Office (USPTO). Information published here is for research/educational purposes only. FreshPatents is not affiliated with the USPTO, assignee companies, inventors, law firms or other assignees. Patent applications, documents and images may contain trademarks of the respective companies/authors. FreshPatents is not responsible for the accuracy, validity or otherwise contents of these public document patent application filings. When possible a complete PDF is provided, however, in some cases the presented document/images is an abstract or sampling of the full patent application for display purposes. FreshPatents.com Terms/Support
-g2-5.1668

66.232.115.224
Next →
← Previous
     SHARE
     

stats Patent Info
Application #
US 20090149391 A1
Publish Date
06/11/2009
Document #
File Date
12/31/1969
USPTO Class
Other USPTO Classes
International Class
/
Drawings
0


Your Message Here(14K)


Food Additives
Galen


Follow us on Twitter
twitter icon@FreshPatents

Ipf Pharmaceuticals Gmbh.

Browse recent Ipf Pharmaceuticals Gmbh. patents

Drug, Bio-affecting And Body Treating Compositions   Designated Organic Active Ingredient Containing (doai)   Peptide Containing (e.g., Protein, Peptones, Fibrinogen, Etc.) Doai   Cyclopeptides   16 To 24 Peptide Repeating Units In Known Peptide Chain  

Browse patents:
Next →
← Previous